Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-003189
Filing Date
2025-05-14
Accepted
2025-05-14 16:46:01
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa20250331_10q.htm   iXBRL 10-Q 1090826
2 EXHIBIT 10.4 ex_816250.htm EX-10.4 41227
3 EXHIBIT 31.1 ex_808927.htm EX-31.1 12146
4 EXHIBIT 31.2 ex_808928.htm EX-31.2 12199
5 EXHIBIT 32.1 ex_808929.htm EX-32.1 5447
6 EXHIBIT 32.2 ex_808930.htm EX-32.2 5361
  Complete submission text file 0001171843-25-003189.txt   5400103

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA edsa-20250331.xsd EX-101.SCH 52208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20250331_def.xml EX-101.DEF 355229
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20250331_lab.xml EX-101.LAB 311607
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20250331_pre.xml EX-101.PRE 383554
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20250331_cal.xml EX-101.CAL 31093
66 EXTRACTED XBRL INSTANCE DOCUMENT edsa20250331_10q_htm.xml XML 771073
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 25946626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)